• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article (55030899)   Find a Category (50)   Find a Journal (6150)   Find a Scholar (3940)   Find an Academic Assistant (17)
Find an Article PDF (4591707)   Today's Articles (1619)   Subscriber (49315)
Total Articles

Ranked By
Results Analysis
  •   
  •   
  •   
  •   
Results Analysis
Year Published
Show more   Refine
Article Statistics
Refine
Publication Titles
Show more   Refine
Grant Agencies
Show more   Refine
Category
Show more   Refine
Number Citation Analysis
1
Durable responses after CD19-targeted CAR-T cell immunotherapy with concurrent ibrutinib for CLL after prior ibrutinib failure. Hematol Oncol 2019. [DOI: 10.1002/hon.126_2629] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
2
HIGH RATE OF DURABLE COMPLETE REMISSION IN FOLLICULAR LYMPHOMA AFTER CD19 CAR-T CELL IMMUNOTHERAPY. Hematol Oncol 2019. [DOI: 10.1002/hon.127_2629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA